Molecular mechanism of Sjogren's syndrome
干燥综合征的分子机制
基本信息
- 批准号:17591027
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.Regulation of SS by analogue peptide of T cell epitopesTo propose the new therapeutic strategies using analogue peptide of T cell epitopes, we focused on muscarinic acetylcholine receptor (M3R). The second extra-cellular domain of M3R is the most important region for intra-cellular signaling. Thus, we analyzed T cell epitopes of the second extra-cellular domain of M3R, screened the analogue peptides of T cell epitopes, and establish an antigen-specific regulation of SS using analogue peptides. 1) We clarified VPPGECFIQFLSEPT (AA215-229) was T cell epitope of M3R in HLA-DR B1*0901 positive patients with SS. 2) We selected two of candidates for analogue T cell epitopes were VPPGECFKQFLSEPT and VPPGECFIAFLSEPT. 3)We established mouse model for SS by the immunization of M3R peptides plus CFA.2.Gene analysis of susceptibility genes in patients with SSTo elucidate susceptibility genes in patients with SS, we analyzed highly expressed genes in labial salivary glands (LSGs) using cDNA microarray. We screened STAT1 gene as a candidate for over-expressed genes. The Tyr701 and Ser727 were phosphorylated and were mainly expressed in LSGs epithelial cells of SS. Moreover, apoptotic genes such as Fas, IP-10, and RF-1 were highly expressed. These results suggest that over-expression of STAT1 might be associated to the apoptosis of LSG epithelial cells in patients with SS.
1.为了提出利用T细胞表位类似肽调控SS的新策略,我们重点研究了毒蕈碱乙酰胆碱受体(muscarinic acetylcholine receptor, M3R)。M3R的第二个胞外结构域是细胞内信号传递最重要的区域。因此,我们分析了M3R第二细胞外结构域的T细胞表位,筛选了T细胞表位的类似肽,并利用类似肽建立了SS的抗原特异性调控。1)我们明确了VPPGECFIQFLSEPT (AA215-229)是HLA-DR B1*0901阳性SS患者M3R的T细胞表位。2)我们选择了两个候选的类似T细胞表位分别是VPPGECFKQFLSEPT和VPPGECFIAFLSEPT。3)采用M3R多肽联合cfa2免疫建立小鼠SS模型。为了阐明SS患者的易感基因,我们利用cDNA芯片分析了唇唾液腺(LSGs)中高表达的基因。我们筛选了STAT1基因作为过表达基因的候选基因。Tyr701和Ser727被磷酸化,主要在SS的LSGs上皮细胞中表达,Fas、IP-10、RF-1等凋亡基因高表达。这些结果提示STAT1的过表达可能与SS患者LSG上皮细胞的凋亡有关。
项目成果
期刊论文数量(24)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A functional variant of Fcg receptor IIIA is associated with rheumatoid arthritis in anti-glucose-6-p-phosphate isomerase antibodies positive individuals.
Fcg 受体 IIIA 的功能变异与抗 6-β-磷酸葡萄糖异构酶抗体阳性个体的类风湿性关节炎有关。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Matsumoto;I.;et al.
- 通讯作者:et al.
DNA microarray analysis of labial salivary glands from patients with Sjogren's syndrome.
干燥综合征患者唇唾液腺的 DNA 微阵列分析。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Wakamatsu;E.;Nakamura;Y;Matsumoto;I;Goto;D;lto;S;Tsutsumi;A;Sumida,T.
- 通讯作者:Sumida,T.
Characterization of Th1 type, glusoce-6-phoshate isomerase reactive T cells in the generation of rheumatoid arthritis.
类风湿性关节炎生成过程中 Th1 型、6-磷酸葡萄糖异构酶反应性 T 细胞的表征。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Kori;Y.;et al.
- 通讯作者:et al.
Characterization of Th1/Th2 type, glusoce-6-phoshate isomerase reactive T cells in the generation of rheumatoid arthritis.
类风湿关节炎生成过程中 Th1/Th2 型、6-磷酸葡萄糖异构酶反应性 T 细胞的表征。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Kori;Y.;Matsumoto;I.;Zhang;H.;Yasukochi;T.;Hayashi;T.;Iwanami;K.;Goto;D.;Ito;S.;Tsutsumi;A.;Sumida;T.
- 通讯作者:T.
TCRVa14+ NKT cells function as effector T cells in collagen-induced arthritis mice.
TCRVa14 NKT 细胞在胶原诱导的关节炎小鼠中充当效应 T 细胞。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Ohnishi;Y.;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUMIDA Takayuki其他文献
SUMIDA Takayuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUMIDA Takayuki', 18)}}的其他基金
Molecular mechanism and regulation in Sjogren's syndrome
干燥综合征的分子机制及调控
- 批准号:
21591260 - 财政年份:2009
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism of Sjogren's syndrome : Immune response to M3R
干燥综合征的分子机制:M3R 的免疫反应
- 批准号:
19591151 - 财政年份:2007
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanism in Sjogren's syndrome
干燥综合征的分子机制
- 批准号:
11470123 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Mechanism in Sjogren's syndrome
干燥综合征的分子机制
- 批准号:
08457157 - 财政年份:1996
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantigen and T cell receptor on infiltrating T cell in labial salivary glands from patients with Sjogren's syndrome.
干燥综合征患者唇唾液腺浸润 T 细胞的自身抗原和 T 细胞受体。
- 批准号:
06670478 - 财政年份:1994
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Prevention of slowly progressive insulin-dependent diabetes mellitus (SPIDDM) targeting autoreactive T cell
针对自身反应性 T 细胞预防缓慢进行性胰岛素依赖型糖尿病 (SPIDDM)
- 批准号:
21K20878 - 财政年份:2021
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of treatment targeting GAD autoreactive T cell in Japanese patients with type 1 diabetes
针对日本 1 型糖尿病患者的 GAD 自身反应性 T 细胞治疗的开发
- 批准号:
20K17497 - 财政年份:2020
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
An acoustofluidic avidity cytometer for massive parallel profiling single autoreactive T cell in autoimmune disease
用于大规模平行分析自身免疫性疾病中单个自身反应性 T 细胞的声流控亲和细胞仪
- 批准号:
10002377 - 财政年份:2020
- 资助金额:
$ 2.05万 - 项目类别:
Does flavivirus infection trigger mitochondrial antigen presentation and autoreactive T-cell response in parkinsonism?
黄病毒感染是否会引发帕金森病中的线粒体抗原呈递和自身反应性 T 细胞反应?
- 批准号:
417351 - 财政年份:2019
- 资助金额:
$ 2.05万 - 项目类别:
Operating Grants
UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
了解自身反应性 T 细胞致病性
- 批准号:
9247751 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别:
UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
了解自身反应性 T 细胞致病性
- 批准号:
8835343 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别:
UNDERSTANDING AUTOREACTIVE T CELL PATHOGENICITY
了解自身反应性 T 细胞致病性
- 批准号:
9462033 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别:
Suppression of autoreactive T cell responses by Th2 cells (28*)
Th2 细胞抑制自身反应性 T 细胞反应 (28*)
- 批准号:
234429963 - 财政年份:2013
- 资助金额:
$ 2.05万 - 项目类别:
Collaborative Research Centres














{{item.name}}会员




